{"issuance_frequency":"","notes_translated":{"fr":"Les exigences relatives au dépistage de la tuberculose chez des volontaires en bonne santé qui participent à des essais cliniques de phase I.","en":"The requirements for tuberculosis screening for certain Phase-I clinical trials in healthy volunteers."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"1f9b09f9-6325-44e8-a7c3-bbf70d3ed2f3","metadata_created":"2021-06-02T18:42:06.113264","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-02T18:42:06.113269","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-02","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["dépistage de la tuberculose","exigences pour le dépistage de la tuberculose","volontaires sains","essais cliniques de phase I","médicaments immunosuppresseurs","médicaments aux propriétés immunosuppressives"],"en":["tuberculosis screening","requirements for tuberculosis screening","healthy volunteers","Phase I clinical trials","immunosuppressant drugs","drugs with immunosuppressant properties"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Mise à jour à l'intention des promoteurs d'essais cliniques : exigences pour le dépistage de la tuberculose chez les volontaires en bonne santé dans le cadre d'essais cliniques de phase I portant sur des immunosuppresseurs ou sur des médicaments ayant des propriétés immunosuppressives","en":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"1f9b09f9-6325-44e8-a7c3-bbf70d3ed2f3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"090299af-d455-4edc-b2eb-0059963b681a","related_relationship":"","name_translated":{"fr":"Mise à jour à l'intention des promoteurs d'essais cliniques : exigences pour le dépistage de la tuberculose chez les volontaires en bonne santé dans le cadre d'essais cliniques de phase I portant sur des immunosuppresseurs ou sur des médicaments ayant des propriétés immunosuppressives","en":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties","language":["en"],"created":"2021-06-02T18:42:06.218994","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/update-clinical-trial-sponsors-requirements-tuberculosis-screening-healthy-volunteers-phase-1-clinical-trials-involving-immunosuppressant-drugs.html","last_modified":null,"position":0,"revision_id":"8dae3ba7-2eed-4538-b422-c002ca81bc26","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"1f9b09f9-6325-44e8-a7c3-bbf70d3ed2f3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ec0c4a1b-b817-47b8-9fec-0e389543719b","related_relationship":"","name_translated":{"fr":"Mise à jour à l'intention des promoteurs d'essais cliniques : exigences pour le dépistage de la tuberculose chez les volontaires en bonne santé dans le cadre d'essais cliniques de phase I portant sur des immunosuppresseurs ou sur des médicaments ayant des propriétés immunosuppressives","en":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties","language":["fr"],"created":"2021-06-02T18:42:06.219000","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/mise-jour-intention-promoteurs-essais-cliniques-exigences-depistage-tuberculose-chez-volontaires-bonne-sante-cadre-essais-cliniques-phase-1-portant.html","last_modified":null,"position":1,"revision_id":"8dae3ba7-2eed-4538-b422-c002ca81bc26","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2007-12-18 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"1f9b09f9-6325-44e8-a7c3-bbf70d3ed2f3","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The requirements for tuberculosis screening for certain Phase-I clinical trials in healthy volunteers.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties","revision_id":"8dae3ba7-2eed-4538-b422-c002ca81bc26"}